Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Anastasia Khvorova

Premium

RNAi researcher Anastasia Khvorova has joined the RNA Therapeutics Institute at the University of Massachusetts Medical School as a professor of molecular medicine.

She most recently served as CSO of RNAi drug developer RXi Pharmaceuticals, and before that was CSO of reagent firm Dharmacon, which was acquired by Thermo Fisher Scientific.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.